Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2019-07-18
Version of Record valid from 2019-07-18
18 July 2019
The authors declare that they have no competing interests.